Rare diseases
Investigational molecules
Locations
Ul. Leona Henryka Sternbacha 2, 30-394 Cracow, Poland
Ryvu Therapeutics S.A. is active in clinical research for acute myeloid leukemia, including disease settings with and without NPM1 mutation, as well as high-risk myelodysplastic syndrome. Its studies also extend to relapsed or refractory aggressive B-cell non-Hodgkin lymphoma, reflecting a strong focus on difficult-to-treat blood cancers.
The sponsor’s hematology portfolio includes both standalone and combination-based therapeutic development in advanced relapsed or refractory disease.
Ryvu Therapeutics S.A. runs clinical trials in conditions such as Acute myeloid leukaemia, Myelofibrosis, Myelodysplastic syndrome, Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceFranceFrance
ItalyFrancePolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
